Even those PEPFAR programs operating must limit distribution of preventive medication, according to apparent State Department ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Michael Alexander Smith, the Chief Legal Officer of Insmed Inc. (NASDAQ:INSM), has recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Smith sold ...

Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock transactions, ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

Osage Beach police found a glass container with approximately 2 grams of methamphetamine with K-9 officer's help last Friday.

Yuka Manabe and her team at the Center for Innovative Diagnostics for Infectious Diseases aim to improve global health with ...

Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.

On Wednesday, the Project 2025 architects returned to court for a hearing in their quest to release the Duke of Sussex’s private immigration documents.